CRYSTAL ADAM (President, R&D) sold 18.9% of their position (27K shares) of TANGO THERAPEUTICS, INC. on the open market
Open‑market sale worth $735.5K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 8/5/2026ACC: 0001193125-26-335002
Officer· President, R&D
Since Feb 2026
-27K
Net shares
Net seller
$735.5K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
27K acquired · 54K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+27K
Price / share
$5.20
Trade value
$140.40K
% of position
23.3%
8/3/2026
115.74K→142.74K
Common Stock
Direct
Shares
−5.27K
Price / share
$26.79
Trade value
$141.10K
% of position
3.7%
8/3/2026
142.74K→137.48K
Common Stock
Direct
Shares
−21.73K
Price / share
$27.35
Trade value
$594.42K
% of position
15.8%
8/3/2026
137.48K→115.74K
Total
Net shares
+0.00
Net value
-$595.12K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/3/2026 | M · Option Exercise | +27K | $5.20 | $140.40K | 23.3% | 115.74K | 142.74K |
| Common Stock Direct | 8/3/2026 | S · Sale | −5.27K | $26.79 | $141.10K | 3.7% | 142.74K | 137.48K |
| Common Stock Direct | 8/3/2026 | S · Sale | −21.73K | $27.35 | $594.42K | 15.8% | 137.48K | 115.74K |
| Total | +0.00 | -$595.12K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
27K shares
Shares
−27K
Strike price
5.2
Held after
287.04K
Exercisable
—
8/3/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock27K shares | 8/3/2026 | M · Option Exercise | −27K | 5.2 | — | 287.04K |